<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="H3F94C7407E5B438EAD64DFF61423CD25" public-private="public" key="H" bill-type="olc"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>119 HR 6117 IH: Patient Device Data Access Act of 2025</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2025-11-18</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">119th CONGRESS</congress><session display="yes">1st Session</session><legis-num display="yes">H. R. 6117</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20251118">November 18, 2025</action-date><action-desc><sponsor name-id="S001207">Ms. Sherrill</sponsor> introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To amend the Federal Food, Drug, and Cosmetic Act to authorize requiring the manufacturers of a covered device to disclose to a patient all patient-specific data that is recorded or transmitted by the device and accessible to the manufacturer, and for other purposes.</official-title></form><legis-body id="H390ECFDDE8E24296BBBC95845DDFA02B" style="OLC"><section id="H26AD8C0556A04963803333CDB4826317" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Patient Device Data Access Act of 2025</short-title></quote>.</text></section><section id="HBC53119F4ECE48AA885D4ED4DBDA44D8"><enum>2.</enum><header>Sharing of patient-specific data by device manufacturers</header><subsection id="H40D6360835CC463FB9370E93D3D0A071"><enum>(a)</enum><header>In general</header><text display-inline="yes-display-inline">Subchapter A of chapter V of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/351">21 U.S.C. 351 et seq.</external-xref>) is amended by adding at the end the following:</text><quoted-block style="OLC" id="HCBC19E84EABE4C5A81FA8A8DAF58174D" display-inline="no-display-inline"><section id="H604D14E0F2F644E79ADF7491C8B36053"><enum>524C.</enum><header>Sharing of patient-specific data by device manufacturers</header><subsection id="HA72340E2AE3641B4BD47BD08A0E988DA"><enum>(a)</enum><header>Requirement authorized</header><text>The Secretary may require the manufacturer of a covered device, at the request of a patient who is using or has used such covered device, to disclose all patient-specific data that is—</text><paragraph id="H03B0C0EB935D4BABA2EE6B9E84AC0880"><enum>(1)</enum><text>recorded or transmitted by such device; and</text></paragraph><paragraph id="H9967CE2D093F4A02908BF38D6875AE90"><enum>(2)</enum><text>accessible to the manufacturer.</text></paragraph></subsection><subsection id="H30C31FBA2D38401A84D4EF494DF94AA2"><enum>(b)</enum><header>Regulations</header><paragraph id="H37BE45684FA449B19A623679485FE034"><enum>(1)</enum><header>Issuance</header><text>Any requirement imposed on manufacturers under subsection (a) shall be by regulation.</text></paragraph><paragraph id="H28FA4A16F38A4271AD90E4C9B78E7080"><enum>(2)</enum><header>Applicability to all manufacturers of covered devices</header><text>Any requirement imposed under subsection (a) shall be applicable with respect to all manufacturers of covered devices.</text></paragraph><paragraph id="HD5742DE1688C4A18B8B8279D23770246"><enum>(3)</enum><header>Consideration</header><text display-inline="yes-display-inline">In issuing any regulation under paragraph (1), the Secretary shall take into consideration the guidance issued in October 2017 by the Food and Drug Administration titled <quote>Manufacturers Sharing Patient-Specific Information from Medical Devices with Patients Upon Request</quote>.</text></paragraph><paragraph id="HD65F5F3440A649CEAA7A58AC6B0478D0"><enum>(4)</enum><header>Contents</header><text>If the Secretary issues regulations under paragraph (1), the Secretary may include in such regulations provisions requiring the manufacturer of a covered device to do the following:</text><subparagraph id="H9F3247941E214DBA8FC478486D449FA5"><enum>(A)</enum><text>At the request of a patient, disclose patient-specific data referred to in subsection (a), where possible—</text><clause id="HD528825F894F423D96DE4E5E5C7BECE2"><enum>(i)</enum><text>in a format that is understandable to the patient; and</text></clause><clause id="H82C1554427A34A9091B3E3146B3DBB52"><enum>(ii)</enum><text display-inline="yes-display-inline">to the extent practicable, in a format preferred by the patient.</text></clause></subparagraph><subparagraph id="H34B58D7D7ED7439C94897C23BB8D5BE6"><enum>(B)</enum><text>Publish on the public website of the manufacturer of a covered device—</text><clause id="H7A09503A6818494B807D93CC0A25B9DA"><enum>(i)</enum><text display-inline="yes-display-inline">an indication that such device is a covered device subject to regulation under this section;</text></clause><clause id="H24ECCF9DDDE44EA383CD2B1A1EFF910F"><enum>(ii)</enum><text>what types of patient-specific data, if any, are—</text><subclause id="HD1DF1D4AD6C2443CA31F51A63467A1C4"><enum>(I)</enum><text>being recorded or transmitted by the covered device; and</text></subclause><subclause id="HFCBD5481A09347AD8E51043E2EB71A06"><enum>(II)</enum><text>accessible to the manufacturer; and</text></subclause></clause><clause id="HC083593E0821461A9A15D1C7A5EFCFA8"><enum>(iii)</enum><text display-inline="yes-display-inline">whether and how the manufacturer utilizes patient data, not including any proprietary information of the manufacturer.</text></clause></subparagraph><subparagraph id="HB1C88992DF1D4BA4BEF426B1D1F8A891"><enum>(C)</enum><text>Make publicly available, by posting on the manufacturer’s website, the method by which patients who are using or have used the covered device may request their own patient-specific data described in subsection (a).</text></subparagraph><subparagraph id="HAE075DD7BE1749B48ABBB00D3CFE4417"><enum>(D)</enum><text>Notify, where possible, patients who are using or have used the covered device about how they can access patient-specific data described in subsection (a).</text></subparagraph><subparagraph id="H255D07280D41497CB6DE972466E685F3"><enum>(E)</enum><text display-inline="yes-display-inline">Notify patients if their covered device is subject to a recall, has a software update, or has generated an error message.</text></subparagraph></paragraph></subsection><subsection id="H8D8844ACADE24D3F8C77FE6C612793E9"><enum>(c)</enum><header>Exceptions</header><text>This section does not authorize the Secretary to require the manufacturer of a covered device—</text><paragraph id="H3E2025F7546E4EBC9213AFE7162A396A"><enum>(1)</enum><text display-inline="yes-display-inline">to disclose data that is—</text><subparagraph id="H2A72F64E7260422AA0ADD1FC3C07BC48"><enum>(A)</enum><text>recorded, transmitted, and retained in a closed system; and</text></subparagraph><subparagraph id="H01BCEC0D6FC14F498395E36F8B95F7D4"><enum>(B)</enum><text>inaccessible to the manufacturer;</text></subparagraph></paragraph><paragraph id="HE2E39496B4FB4EA7833E66D3FBD48CF5"><enum>(2)</enum><text>to redesign the covered device to enable disclosure of patient-specific data; or</text></paragraph><paragraph id="H9E2606FD544F41C19E3A991D48D5FD82"><enum>(3)</enum><text>to disclose patient-specific data that is inaccessible to the manufacturer.</text></paragraph></subsection><subsection id="H8326FD5569404ACF89AD20C13F40A525"><enum>(d)</enum><header>Definitions</header><text>In this section:</text><paragraph id="H56487C0254254103B13826364FC74FC1"><enum>(1)</enum><text display-inline="yes-display-inline">The term <term>covered device</term> means any electronic device that is—</text><subparagraph id="H140064C92E7642F292946AE832E81CF1"><enum>(A)</enum><text>intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease;</text></subparagraph><subparagraph id="H43741735704649C5B5052DF1DF8EA801"><enum>(B)</enum><text>implanted into a patient’s body;</text></subparagraph><subparagraph id="H10F6ED5BB73541A58C08CBFD8C136DF5"><enum>(C)</enum><text>used for the purposes of remote monitoring; and</text></subparagraph><subparagraph id="HEB48DE5771E0402D9146F6AC55032D32"><enum>(D)</enum><text>capable of recording or transmitting patient data.</text></subparagraph></paragraph><paragraph id="HA6DF13628AF74DB9A2EF04879ACB7285"><enum>(2)</enum><text>The term <term>patient-specific data</term>—</text><subparagraph id="HC629E0F3941740F997673D32C769F9A5"><enum>(A)</enum><text>means data unique to an individual patient or unique to the patient’s treatment or diagnosis that is recorded or transmitted by a covered device;</text></subparagraph><subparagraph id="H68AE656F43744F9D83AFFEA051E20C4B"><enum>(B)</enum><text display-inline="yes-display-inline">includes data described in subparagraph (A) irrespective of whether such data, absent regulation under this section, would otherwise be required by law to be disclosed to the patient or their physician; and</text></subparagraph><subparagraph id="H5765CED9D1964942A9B41FCCFE9111AC"><enum>(C)</enum><text>shall include—</text><clause id="H4DCDD320F2944FE88A41ECBECA2C235F"><enum>(i)</enum><text>information recorded by a covered device regarding usage, alarms, or outputs; and</text></clause><clause id="HDA2F258BC1BE491EA4DCF1E740D6FE78"><enum>(ii)</enum><text>pulse oximetry data, heart electrical activity data, and data on rhythms as monitored by a pace maker.</text></clause></subparagraph></paragraph><paragraph id="HF81971C95ECB4C1F8C106DA81C68C95F"><enum>(3)</enum><text display-inline="yes-display-inline">The term <term>inaccessible to the manufacturer</term> means data that is not reasonably accessible.</text></paragraph></subsection></section><after-quoted-block>.</after-quoted-block></quoted-block></subsection><subsection id="HC01103EB86FC43B5A954E8C165D46E89"><enum>(b)</enum><header>Civil penalties</header><text display-inline="yes-display-inline">Section 303(f)(1)(A) of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/333">21 U.S.C. 333(f)(1)(A)</external-xref>) is amended by inserting <quote>, including any such requirement under section 524C,</quote> after <quote>a requirement of this Act which relates to devices</quote>.</text></subsection></section></legis-body></bill>

